Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB05241"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"XL765"
|
| rdf:type | |
| drugbank:description |
"XL765 is an orally available small molecule that has been shown in preclinical studies to selectively inhibit the activity of phosphoinositide-3 kinase (PI3K) and mammalian target of rapamycin (mTOR). It is being developed by Exelixis, Inc."
|
| drugbank:drugCategory |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object